WILMINGTON, Del., Nov. 2, 2023 /PRNewswire/ -- Digital therapeutics often focus on behavior modification and lifestyle changes, making them valuable tools in areas such as addiction treatment, weight management, and mental health.
The global digital therapeutics market was estimated to have acquired US$ 4.5 billion in 2022. It is anticipated to register a 28.6% CAGR from 2023 to 2031 and by 2031, the market is likely to gain US$ 43.2 billion.
The increasing awareness of mental health issues and the demand for mental health support has driven the development of digital therapeutics for conditions like anxiety, depression, and stress management.
Healthcare providers and payers are increasingly incorporating digital therapeutics into their chronic disease management programs, improving patient outcomes and reducing costs.
Download PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85844
Digital Therapeutics Market Report Scope:
Report Coverage | Details |
Forecast Period | 2023-2031 |
Base Year | 2017-2022 |
Size in 2022 | US$ 4.5 Bn |
Forecast (Value) in 2031 | US$ 43.2 Bn |
Growth Rate (CAGR) | 28.6 % |
No. of Pages | 213 Pages |
Segments covered | Application, End-user |
Key Findings of the Market Report
- Digital therapeutics offer an efficient means of conducting remote clinical trials, which has become more important in the context of drug development and testing.
- The proliferation of health and wellness apps, often integrated with digital therapeutics, is making it easier for consumers to proactively manage their health and well being.
- Integrating digital therapeutics with electronic health records can improve care coordination, data sharing, and patient outcomes, enhancing the overall healthcare ecosystem.
- The concept of precision medicine, tailoring treatment to unique genetic and physiological characteristics of an individual, can be complemented by digital therapeutics, which can collect and analyze personal data to inform treatment decisions.
Market Trends for Digital Therapeutics
- The rise in chronic diseases such as diabetes, cardiovascular conditions, and obesity is a significant driver for the digital therapeutics market. Digital therapeutics can provide effective, cost efficient solutions for managing and treating these conditions.
- Escalating healthcare costs are driving the need for more cost effective healthcare solutions. Digital therapeutics offer a cost effective alternative to traditional treatments, reducing the burden on healthcare systems.
- Patient engagement and empowerment are becoming increasingly important in healthcare. Digital therapeutics offer patients tools and platforms to actively participate in their treatment and health management.
- Rapid advancements in technology, including mobile apps, wearables, and IoT devices, have made it easier to develop and deliver digital therapeutic solutions. The technologies improve accessibility and usability.
Enquiry Before Buying @ https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=85844
Global Market for Digital Therapeutics: Regional Outlook
Various reasons are propelling the growth of the digital therapeutics market in different regions. The regions include,
North America
- North America has a high prevalence of chronic diseases such as diabetes, cardiovascular conditions, and obesity. Digital therapeutics offer effective solutions for managing these conditions, making them crucial in the region.
- North America has a well developed healthcare infrastructure, including robust telehealth and digital health ecosystems. The infrastructure provides a conducive environment for the adoption of digital therapeutics.
Asia Pacific
- Asia Pacific has a vast and diverse population, which presents a substantial market for digital therapeutics. The prevalence of chronic diseases in the region further accentuates the need for these solutions.
- Governments in the region are recognizing the potential of digital health solutions to improve healthcare access and reduce costs. Many countries are launching initiatives to promote the adoption of digital therapeutics.
Global Digital Therapeutics Market: Key Players
The following companies are well known participants in the global digital therapeutics market:
- Noom, Inc.
- Teladoc Health, Inc.
- Omada Health Inc.
- WellDoc Inc.
- Pear Therapeutics Inc.
- CogniFit
- Ginger
- Propeller Health
- 2Morrow Inc.
- Canary Health
- Click Therapeutics Inc.
- Akili
- Cognoa
- Wellthy Therapeutics Pvt. Ltd.
- Other Prominent Players
Some key developments by the players in this market are:
Company name | Key Development |
Mahana Therapeutics | In 2023, Mahana Therapeutics entered into a distribution and marketing agreement with Consumer Health division of Bayer to commercialize digital therapeutics. |
AmerisourceBergen Corporation |
In 2023, AmerisourceBergen Corporation announced to launch DTx Connect, a fully integrated ordering, dispensing, and fulfillment platform that aims to facilitate patient access to physician ordered digital therapeutics and diagnostics. |
Big Health | In 2023, Big Health announced the acquisition of Limbix with an aim to strengthen its portfolio by including SparkRx for the treatment of adolescent suffering from depression and anxiety. |
Global Digital Therapeutics Market Segmentation
- Application
- Treatment/Care
- Diabetes
- Cardiovascular Diseases
- Central Nervous System Diseases
- Respiratory Diseases
- Musculoskeletal Diseases
- Medication Adherence
- Others
- Preventive
- Prediabetes
- Obesity
- Smoking Cessation
- Others
- End User
- B2B
- Providers
- Payers
- Employers
- Pharmaceutical Companies
- Others
- B2C
- Patients
- Caregivers
- Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Place an Order Copy of Digital Therapeutics Market Report at: https://www.transparencymarketresearch.com/checkout.php?rep_id=85844<ype=S
More Trending Report by Transparency Market Research:
Ovarian Cancer Treatment Market: The global ovarian cancer treatment market was valued at US$ 5.1 Bn in 2022; It is projected to advance at a CAGR of 15.4% from 2023 to 2031 and reach more than US$ 18.3 Bn by the end of 2031
Anti-inflammatory Therapeutics Market: The global anti-inflammatory therapeutics market was valued at US$ 94.6 Bn in 2022; It is projected to grow at a CAGR of 5.1% from 2023 to 2031 and reach more than US$ 149.5 Bn by the end of 2031
Egypt Diabetes Drugs Market: The Egypt diabetes drugs market in Egypt was valued at US$ 482.8 Mn in 2022; It is projected to grow at a CAGR of 8.0% from 2023 to 2031 and reach more than US$ 993.0 Mn by the end of 2031
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg
View original content:
Voltar noticias em Inglês